InsidersTradesSigma
Discover the full management transaction log of 엔지켐생명과학, a listed issuer based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Healthcare sector, 엔지켐생명과학 has published 3 public disclosures. Market capitalisation: €76.2bn. The latest transaction was reported on 7 April 2026 — Purchase. Among the most active insiders: 브리짓라이프사이언스. All data is free.
FY ended December 2025 · cache
0 of 0 declarations